. Legumain, a direct partner of the cleaved form of VDAC1. A, Schematique representation of VDAC1 cleavage by LGMN. Cytoplasm (Cytop.), mitochondrial outer membrane (OM), mitochondrial intermembrane space (IMS). B, Expression of LGMN and Hsp-90 proteins was quantified in normal (N) and tumoral (T) tissues and LGMN/Hsp-90 ratio was obtained in each patient. C, Representative table of HIF status depending on the mRNA level of CAIX (HIF-1 signature) and Oct4 (HIF-2 signature) in patients from group A and Group B.
. GLI1/IFT20 signature is correlated to primary cilium and VDAC1 in RCC4 cells. A, IFT20 medium fluorescence analysis by FACS in RCC4+pVHL and RCC4 cells. B, RCC4+pVHL cells were transfected with control siRNA (siCtl), siIFT20, siGLI1 and siIFT20/GLI1. Cell lysates were analyzed by immunoblotting for VDAC1 and Actin was used as a loading control. C, Histograms represent the expression of the mRNA of IFT20 (left panel) and GLI1 (right panel) in RCC4 cells in Nx. D, RCC4 cells were transfected with control siRNA (siCtl), siIFT20, siGLI1 and siIFT20/GLI1. Cell lysates were analyzed by immunoblotting for VDAC1 and Actin was used as a loading control. Quantitative analysis of the ciliation percentage was assessed by confocal fluorescence microscopy (n=100-300 cells). E, IFT20 medium fluorescence analysis by FACS in RCC4 cells transfected with control siRNA (siCtl), siVDAC1 and siLGMN. F, Graphic representation of the Boyden chamber cell-based invasion assay using RCC4+pVHL cells transfected with siRNA KIF3A compared to Ctl (siCtl). The mean ±SEM is representative of three independent experiments. A * p<0.05, ** p<0.005 and **** p<0.0005 show significant differences. Experiments have been proceeded without serum. Figure S4 . Modulation of GLI1/IFT20 or LGMN is correlated to primary cilium in RCC4 or RCC4+pVHL cells. A, Histograms represent the overexpression of GLI1 (pGLI1) and IFT20 (pIFT20) at the mRNA level in RCC4 cells in Nx pMock reprents the empty vector. B, RCC4 cells were transfected with control vector (pMock) and pIFT20/GLI1. Quantitative analysis of the ciliation percentage was assessed by confocal fluorescence microscopy (n=100-300 cells). C, Graphic representation of the Boyden chamber cell-based invasion assay using RCC4 cells transfected with pGLI1/ pIFT20 compared to Ctl (pMock). The mean ±SEM is representative of three independent experiments. D, Histograms represent the overexpression of LGMN (pLGMN) at the mRNA level in RCC4+pVHL cells in Nx. E, RCC4+pVHL cells were transfected with control vector (Ctl) and pLGMN. mRNA expression of GLI1 (left panel) and IFT20 (right panel) was quantified in RCC4 cells. F, RCC4+pVHL cells were transfected with control vector (Ctl) and pLGMN. Quantitative analysis of the ciliation percentage was assessed by confocal fluorescence microscopy (n=100-300 cells). G, Graphic representation of the Boyden chamber cell-based invasion assay using RCC4+pVHL cells transfected with pLGMN compared to Ctl. The mean ±SEM is representative of three independent experiments. A * p<0.05, ** p<0.005 and **** p<0.0005 show significant differences. Experiments were conducted without serum. 
Patients (IFT20)
Group 1 (GLI1+/IFT20-) Group 2 (GLI1-/IFT20-) Group 3 (GLI1-/IFT20+) Group 4 (GLI1+/IFT20+) Figure S6 . Cohort A classification. A, Amount of intra-tumor GLI1-and IFT20 mRNA in VHL-and sporadic patients from cohort A. These two groups were separated depending on whether they presented the wild-type or mutated form of pVHL and each of these sub-groups were divided depending on a low or high grade of ccRCC. The mRNA fold change of patients is compared to a pool of healthy kidney tissues.B, HIF-1 and HIF-2 status of the 34 patients from cohort A was obtained by immunohistochemistry using HIF-1α and HIF-2α antibodies and confirmed with the expression pattern of HIF-1/HIF-2 target genes, ca9/bnip3 and pouf5F1/ slc2a1, respectively. Overall survival for the primary cilium signature was calculated from patients of the cohort B using the GLI1/IFT20 signature. Patients without a primary cilium were GLI1-/IFT20-, GLI1+/IFT20-or GLI1-/IFT20+. Patients with primary cilia were GLI1+/IFT20+. Statistical significance (p-value) is indicated. The median survival is also indicated. B, Overall survival for the primary cilium signature was calculated from patients of the cohort C using the GLI1/IFT20 signature. Statistical significance (p-value) is indicated. The median survival is also indicated. C, D and E, Tumors from patients with the primary cilium signature and tumors from patients with no primary cilium were compared. The level of VDAC1 (C), AEP (D) and KI67 (E) mRNA was determined byRNAseq for the TCGA cohort. Statistical significance (p value) is indicated. F, Overall survival of HIF-2 (Oct-4 mRNA expression) or HIF-1/HIF-2 (CA-9 and Oct-4 mRNA expression) patients was calculated from patients of the TCGA Cohort C using the signature. Statistical significance (pvalue) is indicated. The median survival is also indicated. Figure S9 . Flow chart showing classification of the 375 patients from the TCGA ccRCC cohort according to the pVHL, HIF and the primary cilium status. Bioinformatic analysis of the TCGA database of 375 ccRCC patients was used to identify groups without (PC-) and with (PC+) primary cilia depending on the pVHL mutation (mutated pVHL, pVHL-; wild type pVHL, pVHL+), the HIF-1 and -2 status and the primary cilium signature. The median survival is indicated in months (mo.). Figure S10 . Absence of VDAC1-DC promotes aggressiveness in RCC4 but allows response to anti-glycolysis treatments. A, RCC4 and RCC4+pVHL cell lines were incubated in Nx for 72h in the absence or presence of Sunitinib (5µM). B, RCC4 cells were transfected with control siRNA (siCtl), siVDAC1 and siAEP (40nM). RCC4 cell lines were incubated in Nx for 72h in the absence or presence of sunitinib (5µM). Cell mortality was measured using an ADAM cell counter. C, RCC4 and RCC4+pVHL cell lines were incubated in Nx for 72h in the absence or presence of 3BP (25µM). Cell mortality was measured using an ADAM cell counter. D, RCC4 cells were transfected with control siRNA (siCtl), siVDAC1 and siAEP (40nM). RCC4 cell lines were incubated in Nx for 72h in the absence or presence of 3BP (25µM). Cell mortality was measured using an ADAM cell counter. E, Graphic representation of the Boyden chamber cell-based invasion assay using RCC4 cells transfected with siRNA VDAC1 (40nm) compared to Ctl (siCtl) incubated int he absence or presence of 3BP (10µM) for 72h. Invasion assay was performed. * p<0.05, ** p<0.005, *** p<0.0005. Table S5 . Characteristic of patients treated with sunitinib.
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